Skip to content

CD138 + Cyclin D1 API3193DSAA

by Biocare Medical, LLC

Ref API3193DSAA

CD138 + Cyclin D1 API3193DSAA is a multiple solid tumour differentiation marker IVD (EU IVDD general IVD; FDA Class II; FDA product code FDA, Enteroscope And Accessories) made by Biocare Medical, LLC, registered in EUDAMED on 4 Aug 2026 (Basic UDI-DI B-00847627004703) and listed in FDA GUDID since 21 Jun 2023 (UDI-DI 00847627004703), active as of 25 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 25 Oct 2026.

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-00847627004703 Basic UDI-DI 00847627004703UDI-DIDate4 Aug 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00847627004703 UDI-DI Date21 Jun 2023ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 25 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-00847627004703 registered 4 Aug 2026 Active
  • FDA GUDID UDI-DI 00847627004703 listed 21 Jun 2023 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00847627004703
  2. Registered EUDAMED B-00847627004703

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
CD138+CYCLIN D1 EUDAMED
CD138 + Cyclin D1 GUDID
Generic name
Multiple solid tumour differentiation marker IVD, antibody
Model / reference
API3193DSAA
Primary DI / UDI-DI
00847627004703
Basic UDI-DI
B-00847627004703
FDA product code
FDA
EMDN code
W0102039099 Tumour markers - other
GMDN term
Multiple solid tumour differentiation marker IVD, antibody
Device class
Class IVD General EUDAMED
Class II GUDID
Regulation number
876.1500
EU registration type
Legacy device (under a directive)
EU market of registration
Greece
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under TUMOUR MARKERS - OTHER.

Other devices from Biocare Medical, LLC

See all devices from Biocare Medical, LLC →

Properties

  • Contains animal tissues or cells
  • Reagent
  • Professional testing
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (19, all answered No)